Absolute cardiovascular risk (the likelihood of coronary death, non fatal myocardial infarction and stroke over the following 10 yrs), absolute risk reduction and its derived parameter Number Needed to Treat (NNT), constitute, along with relative risk evaluation, the main metrics of “risk-oriented” preventive strategies. “Risk-oriented” medicine, in fact, assumes the existence of a positive association between baseline absolute risk and the number of events prevented by an effective therapeutic intervention. According to that paradigm, confirmed by several randomized clinical trials with statins, patients at higher risk are likely to draw more benefit from “aggressive” treatment of circulating LDL cholesterol. Limitation of that strategy...
Despite the advances in interventional techniques, the management of stable atherosclerosis remains ...
Cardiovascular disease (CVD) remains the leading cause of death worldwide. To date, decades of resea...
Background Primary prevention of cardiovascular disease (CVD) has been traditionally guided by indiv...
Absolute cardiovascular risk (the likelihood of coronary death, non fatal myocardial infarction and ...
Background: Treatment with statins reduces the rate of cardiovascular events in high-risk patients, ...
The Italian Committee for Drugs has recently modified "Appendix 13" to a recent Italian regulation r...
Relative risk for cancer mortality according to lipid-lowering therapy and prevention strategy.</p
Despite substantial progress in the characterization and pharmacological treatment of risk factors a...
International audienceStatins are the pivotal treatment for cardiovascular prevention, whether prima...
Cardiovascular disease (CVD) is the leading cause of death in Italy and in the 28 countries of the E...
The benefits achieved by implementing cardiovascular prevention strategies in terms of reduced incid...
The very high occurrence of cardiovascular events presents a major public health issue, because trea...
Background: In patients with recent ACS, the latest ESC/EAS guidelines for management of dyslipidaem...
Abstract—The concept of risk assessment and reduction, introduced initially by the Framingham Heart ...
<p>* Patients with 1≤CAC<100 are advised to initiate standard statin therapy, which is assumed to pr...
Despite the advances in interventional techniques, the management of stable atherosclerosis remains ...
Cardiovascular disease (CVD) remains the leading cause of death worldwide. To date, decades of resea...
Background Primary prevention of cardiovascular disease (CVD) has been traditionally guided by indiv...
Absolute cardiovascular risk (the likelihood of coronary death, non fatal myocardial infarction and ...
Background: Treatment with statins reduces the rate of cardiovascular events in high-risk patients, ...
The Italian Committee for Drugs has recently modified "Appendix 13" to a recent Italian regulation r...
Relative risk for cancer mortality according to lipid-lowering therapy and prevention strategy.</p
Despite substantial progress in the characterization and pharmacological treatment of risk factors a...
International audienceStatins are the pivotal treatment for cardiovascular prevention, whether prima...
Cardiovascular disease (CVD) is the leading cause of death in Italy and in the 28 countries of the E...
The benefits achieved by implementing cardiovascular prevention strategies in terms of reduced incid...
The very high occurrence of cardiovascular events presents a major public health issue, because trea...
Background: In patients with recent ACS, the latest ESC/EAS guidelines for management of dyslipidaem...
Abstract—The concept of risk assessment and reduction, introduced initially by the Framingham Heart ...
<p>* Patients with 1≤CAC<100 are advised to initiate standard statin therapy, which is assumed to pr...
Despite the advances in interventional techniques, the management of stable atherosclerosis remains ...
Cardiovascular disease (CVD) remains the leading cause of death worldwide. To date, decades of resea...
Background Primary prevention of cardiovascular disease (CVD) has been traditionally guided by indiv...